492 related articles for article (PubMed ID: 23081828)
1. Concise review: The evolution of human pluripotent stem cell culture: from feeder cells to synthetic coatings.
Villa-Diaz LG; Ross AM; Lahann J; Krebsbach PH
Stem Cells; 2013 Jan; 31(1):1-7. PubMed ID: 23081828
[TBL] [Abstract][Full Text] [Related]
2. Culture conditions affect cardiac differentiation potential of human pluripotent stem cells.
Ojala M; Rajala K; Pekkanen-Mattila M; Miettinen M; Huhtala H; Aalto-Setälä K
PLoS One; 2012; 7(10):e48659. PubMed ID: 23119085
[TBL] [Abstract][Full Text] [Related]
3. Facile engineering of xeno-free microcarriers for the scalable cultivation of human pluripotent stem cells in stirred suspension.
Fan Y; Hsiung M; Cheng C; Tzanakakis ES
Tissue Eng Part A; 2014 Feb; 20(3-4):588-99. PubMed ID: 24098972
[TBL] [Abstract][Full Text] [Related]
4. A novel feeder-free culture system for human pluripotent stem cell culture and induced pluripotent stem cell derivation.
Vuoristo S; Toivonen S; Weltner J; Mikkola M; Ustinov J; Trokovic R; Palgi J; Lund R; Tuuri T; Otonkoski T
PLoS One; 2013; 8(10):e76205. PubMed ID: 24098444
[TBL] [Abstract][Full Text] [Related]
5. Controlled Growth and the Maintenance of Human Pluripotent Stem Cells by Cultivation with Defined Medium on Extracellular Matrix-Coated Micropatterned Dishes.
Takenaka C; Miyajima H; Yoda Y; Imazato H; Yamamoto T; Gomi S; Ohshima Y; Kagawa K; Sasaki T; Kawamata S
PLoS One; 2015; 10(6):e0129855. PubMed ID: 26115194
[TBL] [Abstract][Full Text] [Related]
6. GMP scale-up and banking of pluripotent stem cells for cellular therapy applications.
Ausubel LJ; Lopez PM; Couture LA
Methods Mol Biol; 2011; 767():147-59. PubMed ID: 21822873
[TBL] [Abstract][Full Text] [Related]
7. The suspension culture of undifferentiated human pluripotent stem cells using spinner flasks.
Chen VC; Couture LA
Methods Mol Biol; 2015; 1283():13-21. PubMed ID: 25537838
[TBL] [Abstract][Full Text] [Related]
8. Feeder-independent culture systems for human pluripotent stem cells.
Moody J
Methods Mol Biol; 2013; 946():507-21. PubMed ID: 23179852
[TBL] [Abstract][Full Text] [Related]
9. Culture, Adaptation, and Expansion of Pluripotent Stem Cells.
Brehm JL; Ludwig TE
Methods Mol Biol; 2017; 1590():139-150. PubMed ID: 28353267
[TBL] [Abstract][Full Text] [Related]
10. Xeno-free culture of human pluripotent stem cells.
Bergström R; Ström S; Holm F; Feki A; Hovatta O
Methods Mol Biol; 2011; 767():125-36. PubMed ID: 21822871
[TBL] [Abstract][Full Text] [Related]
11. Development of humanized culture medium with plant-derived serum replacement for human pluripotent stem cells.
Kunova M; Matulka K; Eiselleova L; Trckova P; Hampl A; Dvorak P
Reprod Biomed Online; 2010 Nov; 21(5):676-86. PubMed ID: 20884295
[TBL] [Abstract][Full Text] [Related]
12. Noggin maintains pluripotency of human embryonic stem cells grown on Matrigel.
Chaturvedi G; Simone PD; Ain R; Soares MJ; Wolfe MW
Cell Prolif; 2009 Aug; 42(4):425-33. PubMed ID: 19500111
[TBL] [Abstract][Full Text] [Related]
13. Production of human pluripotent stem cell therapeutics under defined xeno-free conditions: progress and challenges.
Fan Y; Wu J; Ashok P; Hsiung M; Tzanakakis ES
Stem Cell Rev Rep; 2015 Feb; 11(1):96-109. PubMed ID: 25077810
[TBL] [Abstract][Full Text] [Related]
14. Adaptation of human pluripotent stem cells to feeder-free conditions in chemically defined medium with enzymatic single-cell passaging.
Stover AE; Schwartz PH
Methods Mol Biol; 2011; 767():137-46. PubMed ID: 21822872
[TBL] [Abstract][Full Text] [Related]
15. Design of a Vitronectin-Based Recombinant Protein as a Defined Substrate for Differentiation of Human Pluripotent Stem Cells into Hepatocyte-Like Cells.
Nagaoka M; Kobayashi M; Kawai C; Mallanna SK; Duncan SA
PLoS One; 2015; 10(8):e0136350. PubMed ID: 26308339
[TBL] [Abstract][Full Text] [Related]
16. Generation of functional cardiomyocytes from rat embryonic and induced pluripotent stem cells using feeder-free expansion and differentiation in suspension culture.
Dahlmann J; Awad G; Dolny C; Weinert S; Richter K; Fischer KD; Munsch T; Leßmann V; Volleth M; Zenker M; Chen Y; Merkl C; Schnieke A; Baraki H; Kutschka I; Kensah G
PLoS One; 2018; 13(3):e0192652. PubMed ID: 29513687
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effect of medium, matrix, and exogenous factors on the adhesion and growth of human pluripotent stem cells under defined, xeno-free conditions.
Meng G; Liu S; Rancourt DE
Stem Cells Dev; 2012 Jul; 21(11):2036-48. PubMed ID: 22149941
[TBL] [Abstract][Full Text] [Related]
18. Autogeneic feeders for the culture of undifferentiated human embryonic stem cells in feeder and feeder-free conditions.
Choo A; Ngo AS; Ding V; Oh S; Kiang LS
Methods Cell Biol; 2008; 86():15-28. PubMed ID: 18442642
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of oligodendrocyte progenitor cells from dissociated monolayer and feeder-free cultured pluripotent stem cells.
Yamashita T; Miyamoto Y; Bando Y; Ono T; Kobayashi S; Doi A; Araki T; Kato Y; Shirakawa T; Suzuki Y; Yamauchi J; Yoshida S; Sato N
PLoS One; 2017; 12(2):e0171947. PubMed ID: 28192470
[TBL] [Abstract][Full Text] [Related]
20. Reduction of N-glycolylneuraminic acid in human induced pluripotent stem cells generated or cultured under feeder- and serum-free defined conditions.
Hayashi Y; Chan T; Warashina M; Fukuda M; Ariizumi T; Okabayashi K; Takayama N; Otsu M; Eto K; Furue MK; Michiue T; Ohnuma K; Nakauchi H; Asashima M
PLoS One; 2010 Nov; 5(11):e14099. PubMed ID: 21124894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
